Pachyonychia congenita type 2

Common Name(s)

Pachyonychia congenita type 2

See Pachyonychia Congenita. Pachyonychia congenita Jackson Lawler type is listed incorrectly as a separate type of Pachyonychia Congenita. The former classification system of PC Type 1 and PC Type 2 has been replaced by a more correct, genetically-based classification (see McLean, Journal of Investigative Dermatology, May 2011).

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Pachyonychia congenita type 2" for support, advocacy or research.

Pachyonychia Congenita Project

Our mission is to develop and deliver effective treatments for Pachyonychia Congenita patients worldwide. Activities include research grants, educational outreach programs, Int'l PC Consortium annual scientific symposium, patient support meetings held annually, an IRB-approved research registry, free genetic testing and webinars and other support services for patients, families,

Last Updated: 1 May 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Pachyonychia congenita type 2" for support, advocacy or research.

Pachyonychia Congenita Project

Our mission is to develop and deliver effective treatments for Pachyonychia Congenita patients worldwide. Activities include research grants, educational outreach programs, Int'l PC Consortium annual scientific symposium, patient support meetings held annually, an IRB-approved research registry, free genetic testing and webinars and other support services for patients, families,

http://www.pachyonychia.org

Last Updated: 1 May 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

General Resources

Updated 1 May 2014

Open Doc
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Pachyonychia congenita type 2" returned 7 free, full-text research articles on human participants. First 3 results:

Pachyonychia congenita type 2.
 

Author(s): Jayanta Kumar Das, Sujata Sengupta, Asok Gangopadhyay

Journal: Indian J Dermatol Venereol Leprol. ;75(3):321-2.

 

Last Updated: 14 May 2009

Go To URL
A novel mutation in K6b in pachyonychia congenita type 2.
 

Author(s): Vishakha M Sharma, Sarah L Stein

Journal: J. Invest. Dermatol.. 2007 Aug;127(8):2060-2.

 

Last Updated: 16 Jul 2007

Go To URL
A novel mutation in the second half of the keratin 17 1A domain in a large pedigree with delayed-onset pachyonychia congenita type 2.
 

Author(s): Sheng-Xiang Xiao, Yi-Guo Feng, Xiao-Rong Ren, Sheng-Shun Tan, Li Li, Jun-Min Wang, Yao-Zhou Shi

Journal: J. Invest. Dermatol.. 2004 Apr;122(4):892-5.

 

Pachyonychia congenita type 2 (PC-2), also known as Jackson-Lawler type PC, is an autosomal dominant disorder characterized by hypertrophic nail dystrophy associated with focal keratoderma and multiple pilosebaceous cysts. We report a large Chinese pedigree of typical delayed-onset ...

Last Updated: 22 Apr 2004

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Pachyonychia congenita type 2" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.